Anzeige
Mehr »
Login
Donnerstag, 06.02.2025 Börsentäglich über 12.000 News von 685 internationalen Medien
Medizin-Wende naht?: Durchbruch im Kampf gegen Krebs? Diese Nasdaq-Aktie könnte Geschichte schreiben!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Medien-Archiv vom 09.01.2025

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
09.01.Arkema: Statement about the Number of Shares and Voting Rights in Compliance With the Article L.233-8 II of the French Commercial Code and the Article 223-16 of the Financial Markets Authority...146Regulatory News: Statement about the number of shares and voting rights in compliance with the article L.233-8 II of the French commercial code and the article 223-16 of the Financial Markets...
► Artikel lesen
09.01.Nationalbank erwirtschaftet Milliardengewinn-
09.01.Das WEF findet 78 Millionen neue Jobs-
09.01.U.S. surgeon general has warned about alcohol and cancer risk. What should providers do?-
09.01.Press Ganey: Where payers should be focusing their member experience efforts-
09.01.'It reminds me of Bitcoin': Healthcare execs split on ICHRAs-
09.01.UnitedHealth, Amedisys ask court to dismiss DOJ's challenge to $3.3B merger deal-
09.01.2024 a mixed bag for health tech venture capital: HSBC report-
09.01.NORTHWEST NATURAL GAS CO - 8-K, Current Report-
09.01.Qomolangma Acquisition Corp. - 8-K, Current Report-
09.01.Enad Global 7 AB: Enad Global 7 initiates a wind down of the operations in Toadman59As part of Enad Global 7's (EG7) efforts to deliver on the groups long term strategy, the Board of Directors has initiated the process to wind down the operations in Toadman. This decision does not...
► Artikel lesen
09.01.Xbrane Biopharma AB: Xbrane Biopharma appoints Jane Benyamin as acting Chief Financial Officer73Xbrane announces today that it has appointed Jane Benyamin as acting CFO as of January 9, 2025. As previously announced, the company's current CFO, Anette Lindqvist, is stepping down from the role of...
► Artikel lesen
09.01.Netum Group Oyj: Change in Netum Group Plc's Board of Directors and Management Team - new CEO Repe Harmanen to start in his position on 10 January 202520Netum Group Plc | Company announcement | 9 January 2025 at 3:00 p.m. EET Change in Netum Group Plc's Board of Directors and Management Team - new CEO Repe Harmanen to start in his position on 10 January...
► Artikel lesen
09.01.H. Lundbeck A/S: Lundbeck announces FDA plans to host an Advisory Committee meeting on the sNDA for brexpiprazole in combination with sertraline for the treatment of adults with PTSD126H. Lundbeck A/S (Lundbeck) announces that the U.S. Food and Drug Administration (FDA) plans to host a Psychopharmacologic Drugs Advisory Committee (PDAC) meeting to seek input on issues related to the...
► Artikel lesen
09.01.Gatos Silver, Inc.: Gatos Silver Reports 2024 Production at the Top End of Guidance128VANCOUVER, British Columbia, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Gatos Silver, Inc. (NYSE/TSX: GATO) ("Gatos Silver" or the "Company") today announced production results for the quarter and year ended...
► Artikel lesen
09.01.ImmuCell Corporation: ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year 2024446PORTLAND, Maine, Jan. 09, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically...
► Artikel lesen
09.01.Zefiro Methane Corp. Releases Updated Corporate Presentation Reflecting 2024 Growth140FORT LAUDERDALE, Fla., Jan. 09, 2025 (GLOBE NEWSWIRE) -- ZEFIRO METHANE CORP. (Cboe Canada: ZEFI) (Frankfurt: Y6B) (OTCQB: ZEFIF) (the "Company", "Zefiro", or "ZEFI"), an environmental services company...
► Artikel lesen
09.01.Aptose Biosciences, Inc.: Aptose Announces First AML Patients Dosed with Tuspetinib Triplet Frontline Therapy in TUSCANY Trial1.298SAN DIEGO and TORONTO, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company, today announced...
► Artikel lesen
09.01.Mural Oncology, Inc.: Mural Oncology Highlights Pipeline Progress and Anticipated 2025 Catalysts114Readouts for two late-stage, potentially registrational trials of nemvaleukin alfa expected in late Q1/early Q2 2025 for platinum-resistant ovarian cancer and Q2 2025 for mucosal melanoma Preliminary...
► Artikel lesen
09.01.Intellia Therapeutics, Inc.: Intellia Therapeutics Announces Anticipated 2025 Milestones and Strategic Reorganization to Prioritize the Advancement of its Late-Stage Programs, NTLA-2002 and Nexiguran Ziclumeran (nex-z)154Priority programs - NTLA-2002 for hereditary angioedema (HAE) and nexiguran ziclumeran (nex-z) for transthyretin (ATTR) amyloidosis - set foundation for significant, near-term value creation Phase...
► Artikel lesen
Seite:  Weiter >>
Suchbegriffe der letzen 24 hAnzahl
NVIDIA5.186
EVOTEC4.495
TUI3.036
PALANTIR TECHNOLOGIES3.015
BAYER2.623
PUMA2.515
BYD2.401
D-WAVE QUANTUM2.347
TESLA2.230
RHEINMETALL2.151
AMD2.126
NOVO NORDISK2.105
ALPHABET1.908
DEUTSCHE BANK1.786
VALNEVA1.769
PAYPAL1.658
BASF1.636
SIEMENS ENERGY1.602
SUPER MICRO COMPUTER1.414
RENK GROUP1.299
COMMERZBANK1.226
AMAZON1.213
NEL1.213
ALMONTY1.178
INFINEON1.152